96 related articles for article (PubMed ID: 1908851)
1. Malignant cell detection in Burkitt's lymphoma using third-complementarity-determining region (CDRIII), clone-specific probe developed by sequencing DNA from stored slides.
Asada M; Miyashita T; Bessho F; Kobayashi N; Mizutani S
Jpn J Cancer Res; 1991 Jul; 82(7):848-53. PubMed ID: 1908851
[TBL] [Abstract][Full Text] [Related]
2. Detection of minimal residual disease using clonospecific primers for CDRIII in patients with acute B lymphocytic leukemia with or without Philadelphia chromosome: possibility of clinical application as a tool for improving prognosis.
Maeda Y; Horiuchi F; Morita S; Matsuda M; Shirakawa C; Masaki H; Koyama A; Hamazaki H; Fujimoto T; Irimajiri K
Exp Hematol; 1994 Aug; 22(9):881-7. PubMed ID: 8062887
[TBL] [Abstract][Full Text] [Related]
3. Identification and structural analysis of rearranged immunoglobulin heavy chain genes in lymphomas and leukemias.
Linke B; Pyttlich J; Tiemann M; Suttorp M; Parwaresch R; Hiddemann W; Kneba M
Leukemia; 1995 May; 9(5):840-7. PubMed ID: 7769847
[TBL] [Abstract][Full Text] [Related]
4. Detection of minimal disease in hematopoietic malignancies of the B-cell lineage by using third-complementarity-determining region (CDR-III)-specific probes.
Yamada M; Hudson S; Tournay O; Bittenbender S; Shane SS; Lange B; Tsujimoto Y; Caton AJ; Rovera G
Proc Natl Acad Sci U S A; 1989 Jul; 86(13):5123-7. PubMed ID: 2500663
[TBL] [Abstract][Full Text] [Related]
5. Absence of Ig V region gene somatic hypermutation in advanced Burkitt's lymphoma.
Carroll WL; Yu M; Link MP; Korsmeyer SJ
J Immunol; 1989 Jul; 143(2):692-8. PubMed ID: 2500485
[TBL] [Abstract][Full Text] [Related]
6. Detection of clonality in childhood B-lineage acute lymphoblastic leukaemia by the polymerase chain reaction.
Potter MN; Steward CG; Maitland NJ; Oakhill A
Leukemia; 1992 Apr; 6(4):289-94. PubMed ID: 1588791
[TBL] [Abstract][Full Text] [Related]
7. An evaluation of minimal residual disease in childhood acute lymphoblastic leukaemia.
Yeoh AE; Quah TC; Jeyaseelan K; Lee BW; Poh KS; Sun L
Ann Acad Med Singap; 1997 May; 26(3):365-71. PubMed ID: 9285034
[TBL] [Abstract][Full Text] [Related]
8. Identification of an altered immunoglobulin heavy-chain gene rearrangement in the central nervous system in B-precursor acute lymphoblastic leukemia.
Wasserman R; Felix CA; McKenzie SE; Shane S; Lange B; Finger LR
Leukemia; 1993 Aug; 7(8):1294-9. PubMed ID: 8350631
[TBL] [Abstract][Full Text] [Related]
9. Combined polymerase chain reaction methods to detect c-myc/IgH rearrangement in childhood Burkitt's lymphoma for minimal residual disease analysis.
Busch K; Borkhardt A; Wössmann W; Reiter A; Harbott J
Haematologica; 2004 Jul; 89(7):818-25. PubMed ID: 15257933
[TBL] [Abstract][Full Text] [Related]
10. Burkitt's lymphoma cell lines producing truncated mu immunoglobulin heavy chains lacking part of the variable region.
Cogné M; Mounir S; Preud'homme JL; Nau F; Guglielmi P
Eur J Immunol; 1988 Oct; 18(10):1485-9. PubMed ID: 2847931
[TBL] [Abstract][Full Text] [Related]
11. Use of UITma DNA polymerase improves the PCR detection of rearranged immunoglobulin heavy chain CDR3 junctions.
Linke B; Bolz I; Pott C; Hiddemann W; Kneba M
Leukemia; 1995 Dec; 9(12):2133-7. PubMed ID: 8609729
[TBL] [Abstract][Full Text] [Related]
12. Production of an abnormal mu chain with a shortened VHIV subgroup variable region in a Burkitt's lymphoma cell line.
Cogné M; Mounir S; Mahdi T; Preud'homme JL; Nau F; Guglielmi P
Mol Immunol; 1990 Sep; 27(9):929-34. PubMed ID: 2120579
[TBL] [Abstract][Full Text] [Related]
13. A reliable approach for sequencing clone-specific CDRIII regions in B-cell lymphoma.
Straka C; Pettengell R; Pielmeier A; Cross M; Emmerich B; Crowther D; Testa NG; Dexter TM
Ann Oncol; 1994; 5 Suppl 1():79-84. PubMed ID: 8172824
[TBL] [Abstract][Full Text] [Related]
14. Obtaining clone-specific primer and probe for the immunoglobulin heavy-chain gene from paraffin-embedded tissue of B-cell lymphoma: technical considerations.
Wu G; Greiner TC; Chang WC
Diagn Mol Pathol; 1997 Jun; 6(3):147-53. PubMed ID: 9276186
[TBL] [Abstract][Full Text] [Related]
15. [Molecular genetic features of sporadic Burkitt's lymphoma in children].
Yang WP; Huang H; Gong LP; Wu Y; Xu HY; Zou Y; Lü BB; Zhong HS; Deng QQ; Xiao Q; Zeng ST; Zhu CD
Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):819-24. PubMed ID: 21215097
[TBL] [Abstract][Full Text] [Related]
16. The c-MYC allele that is translocated into the IgH locus undergoes constitutive hypermutation in a Burkitt's lymphoma line.
Bemark M; Neuberger MS
Oncogene; 2000 Jul; 19(30):3404-10. PubMed ID: 10918597
[TBL] [Abstract][Full Text] [Related]
17. A particular characteristic of IgH complementarity-determining region 3 suggests autoreactive B-cell origin of primary gastric B-cell lymphomas.
Yumoto N; Furukawa M; Kurosu K; Mikata A
Lab Invest; 1998 Mar; 78(3):261-8. PubMed ID: 9520939
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of immunoglobulin genes in primary intraocular lymphoma.
Coupland SE; Hummel M; Müller HH; Stein H
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3507-14. PubMed ID: 16186327
[TBL] [Abstract][Full Text] [Related]
19. Burkitt's lymphoma is a malignancy of mature B cells expressing somatically mutated V region genes.
Klein U; Klein G; Ehlin-Henriksson B; Rajewsky K; Küppers R
Mol Med; 1995 Jul; 1(5):495-505. PubMed ID: 8529116
[TBL] [Abstract][Full Text] [Related]
20. VH gene analysis in sporadic Burkitt's lymphoma: somatic mutation and intraclonal diversity with special reference to the tumor cells involving germinal center.
Isobe K; Tamaru J; Nakamura S; Harigaya K; Mikata A; Ito H
Leuk Lymphoma; 2002 Jan; 43(1):159-64. PubMed ID: 11908722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
